183 related articles for article (PubMed ID: 15567300)
1. Permeability modulation of human intestinal Caco-2 cell monolayers by interferons.
Kawaguchi H; Akazawa Y; Watanabe Y; Takakura Y
Eur J Pharm Biopharm; 2005 Jan; 59(1):45-50. PubMed ID: 15567300
[TBL] [Abstract][Full Text] [Related]
2. Transport of rhodamine 123, a P-glycoprotein substrate, across rat intestine and Caco-2 cell monolayers in the presence of cytochrome P-450 3A-related compounds.
Yumoto R; Murakami T; Nakamoto Y; Hasegawa R; Nagai J; Takano M
J Pharmacol Exp Ther; 1999 Apr; 289(1):149-55. PubMed ID: 10086998
[TBL] [Abstract][Full Text] [Related]
3. Effect of benzo[a]pyrene on P-glycoprotein-mediated transport in Caco-2 cell monolayer.
Sugihara N; Toyama K; Michihara A; Akasaki K; Tsuji H; Furuno K
Toxicology; 2006 Jun; 223(1-2):156-65. PubMed ID: 16647797
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the permeability of H2 receptor antagonists cimetidine and ranitidine by P-glycoprotein in rat intestine and the human colonic cell line Caco-2.
Collett A; Higgs NB; Sims E; Rowland M; Warhurst G
J Pharmacol Exp Ther; 1999 Jan; 288(1):171-8. PubMed ID: 9862768
[TBL] [Abstract][Full Text] [Related]
5. Enhancing effect of N-octyl-O-sulfate chitosan on etoposide absorption.
Mo R; Xiao Y; Sun M; Zhang C; Ping Q
Int J Pharm; 2011 May; 409(1-2):38-45. PubMed ID: 21356302
[TBL] [Abstract][Full Text] [Related]
6. Transport of hop bitter acids across intestinal Caco-2 cell monolayers.
Cattoor K; Bracke M; Deforce D; De Keukeleire D; Heyerick A
J Agric Food Chem; 2010 Apr; 58(7):4132-40. PubMed ID: 20329731
[TBL] [Abstract][Full Text] [Related]
7. Transport characteristics of rutin deca (H-) sulfonate sodium across Caco-2 cell monolayers.
He Y; Zeng S
J Pharm Pharmacol; 2005 Oct; 57(10):1297-303. PubMed ID: 16259758
[TBL] [Abstract][Full Text] [Related]
8. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.
Sachs-Barrable K; Thamboo A; Lee SD; Wasan KM
J Pharm Pharm Sci; 2007; 10(3):319-31. PubMed ID: 17727795
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of the naringin low uptake by intestinal Caco-2 cells.
Tourniaire F; Hassan M; André M; Ghiringhelli O; Alquier C; Amiot MJ
Mol Nutr Food Res; 2005 Oct; 49(10):957-62. PubMed ID: 16189799
[TBL] [Abstract][Full Text] [Related]
10. Methadone inhibits rhodamine123 transport in Caco-2 cells.
Störmer E; Perloff MD; von Moltke LL; Greenblatt DJ
Drug Metab Dispos; 2001 Jul; 29(7):954-6. PubMed ID: 11408360
[TBL] [Abstract][Full Text] [Related]
11. Effect of nonylphenol ethoxylates (NPEs) on barrier functions of epithelial cell membranes: opening of tight junctions and competitive inhibition of P-gp-mediated efflux.
Doo MH; Li H; Jang HI; Song IS; Chung SJ; Shim CK
Int J Pharm; 2005 Sep; 302(1-2):145-53. PubMed ID: 16111844
[TBL] [Abstract][Full Text] [Related]
12. Contribution of P-glycoprotein to the enhancing effects of dimethyl-beta-cyclodextrin on oral bioavailability of tacrolimus.
Arima H; Yunomae K; Hirayama F; Uekama K
J Pharmacol Exp Ther; 2001 May; 297(2):547-55. PubMed ID: 11303042
[TBL] [Abstract][Full Text] [Related]
13. Transport characteristics of zolmitriptan in a human intestinal epithelial cell line Caco-2.
Yu L; Zeng S
J Pharm Pharmacol; 2007 May; 59(5):655-60. PubMed ID: 17524230
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of P-glycoprotein-mediated transport by terpenoids contained in herbal medicines and natural products.
Yoshida N; Koizumi M; Adachi I; Kawakami J
Food Chem Toxicol; 2006 Dec; 44(12):2033-9. PubMed ID: 16904803
[TBL] [Abstract][Full Text] [Related]
15. Effects of citrus fruit juices on cytotoxicity and drug transport pathways of Caco-2 cell monolayers.
Lim SL; Lim LY
Int J Pharm; 2006 Jan; 307(1):42-50. PubMed ID: 16260103
[TBL] [Abstract][Full Text] [Related]
16. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE
Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606
[TBL] [Abstract][Full Text] [Related]
17. Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana.
Zhu HJ; Wang JS; Markowitz JS; Donovan JL; Gibson BB; Gefroh HA; Devane CL
J Pharmacol Exp Ther; 2006 May; 317(2):850-7. PubMed ID: 16439618
[TBL] [Abstract][Full Text] [Related]
18. [Absorption of papaverine, laudanosine and cepharanthine across human intestine by using human Caco-2 cells monolayers model].
Ma L; Yang XW
Yao Xue Xue Bao; 2008 Feb; 43(2):202-7. PubMed ID: 18507350
[TBL] [Abstract][Full Text] [Related]
19. Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers.
Ingels F; Beck B; Oth M; Augustijns P
Int J Pharm; 2004 Apr; 274(1-2):221-32. PubMed ID: 15072798
[TBL] [Abstract][Full Text] [Related]
20. The effect of conjugated linoleic acid and medium-chain fatty acids on transepithelial calcium transport in human intestinal-like Caco-2 cells.
Jewell C; Cashman KD
Br J Nutr; 2003 May; 89(5):639-47. PubMed ID: 12720584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
